These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 38764558)
1. Prevalence of Classical Extraintestinal Manifestations among Inflammatory Bowel Disease Patients in Saudi Arabia: A Single Tertiary Center Experience. Alotaibi A; Alhubayshi A; Allehibi A; Almtawa A; Alotaibi N; Alghamdi A; Alrajhi S; Alqutub A; Aleid A; Alamr A; Ibrahim B; Alahmari M; Alhamidi H; Ahmad S; AlBayyat H; Alshaya O; Altannir Y; Alghamdi A Saudi J Med Med Sci; 2024; 12(2):169-174. PubMed ID: 38764558 [TBL] [Abstract][Full Text] [Related]
2. Temporal Relationship of Extraintestinal Manifestations in Inflammatory Bowel Disease. Fedor I; Zold E; Barta Z J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945280 [TBL] [Abstract][Full Text] [Related]
3. Clinical Features Focusing on Extraintestinal Manifestations in Japanese Patients with Inflammatory Bowel Diseases: Far East 1000. Ohta Y; Taida T; Kato J; Ogasawara S; Oyama Y; Mamiya Y; Nakazawa H; Horio R; Goto C; Takahashi S; Kurosugi A; Sonoda M; Shiratori W; Kaneko T; Yokoyama Y; Akizue N; Ishigami H; Koseki H; Okimoto K; Saito K; Saito M; Matsumura T; Nakagawa T; Masuya Y; Fukuda Y; Kitsukawa Y; Shimura H; Tsuyuguchi T; Kato N Digestion; 2023; 104(4):328-334. PubMed ID: 36893744 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease. Khrom M; Long M; Dube S; Robbins L; Botwin GJ; Yang S; Mengesha E; Li D; Naito T; Bonthala NN; Ha C; Melmed G; Rabizadeh S; Syal G; Vasiliauskas E; Ziring D; Brant SR; Cho J; Duerr RH; Rioux J; Schumm P; Silverberg M; Ananthakrishnan AN; Faubion WA; Jabri B; Lira SA; Newberry RD; Sandler RS; Xavier RJ; Kugathasan S; Hercules D; Targan SR; Sartor RB; Haritunians T; McGovern DPB Gastroenterology; 2024 Jul; 167(2):315-332. PubMed ID: 38490347 [TBL] [Abstract][Full Text] [Related]
5. Extraintestinal Manifestations of Inflammatory Bowel Disease in Middle Eastern Patients. Adam H; Alqassas M; Saadah OI; Mosli M J Epidemiol Glob Health; 2020 Dec; 10(4):298-303. PubMed ID: 32959603 [TBL] [Abstract][Full Text] [Related]
6. Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: Frequency and relation with disease phenotype. Singh B; Kedia S; Konijeti G; Mouli VP; Dhingra R; Kurrey L; Srivastava S; Pradhan R; Makharia G; Ahuja V Indian J Gastroenterol; 2015 Jan; 34(1):43-50. PubMed ID: 25663290 [TBL] [Abstract][Full Text] [Related]
7. Factors Associated With Extraintestinal Manifestations of Inflammatory Bowel Disease in SPARC-IBD. Alizadeh M; Motwani K; Siaton BC; Abutaleb A; Ravel J; Cross RK; Inflamm Bowel Dis; 2024 Nov; 30(11):2027-2036. PubMed ID: 38102817 [TBL] [Abstract][Full Text] [Related]
9. Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry. Algaba A; Guerra I; Ricart E; Iglesias E; Mañosa M; Gisbert JP; Guardiola J; Mínguez M; Castro B; de Francisco R; Nos P; Bertoletti F; Mesonero F; Barrio J; Martín-Arranz MD; Calvet X; García-López S; Sicilia B; Alcaín G; Esteve M; Márquez L; Piqueras M; Jiménez L; Perez-Calle JL; Bujanda L; García-Sepulcre M; Fernández A; Moraleja I; Lorente RH; García-Bosch O; Lambán A; Blázquez I; Rodríguez E; Huguet JM; Lucendo AJ; Almela P; Busquets D; Ramírez de la Piscina P; Pérez M; Domenech E; Bermejo F; Dig Dis Sci; 2021 Jun; 66(6):2014-2023. PubMed ID: 32671587 [TBL] [Abstract][Full Text] [Related]
10. Extraintestinal manifestation of inflammatory bowel disease in Asian patients: A multinational study. Park SK; Wong Z; Park SH; Vu KV; Bang KB; Piyachaturawat P; Myint T; Hilmi I; Park DI Dig Liver Dis; 2021 Feb; 53(2):196-201. PubMed ID: 32736897 [TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Extraintestinal Manifestations in Inflammatory Bowel Diseases - Data from the Romanian National Registry. Singeap AM; Girleanu I; Diculescu M; Gheorghe L; Ciocîrlan M; Gheorghe C; Costache A; Tanțău A; Zaharie R; Goldis A; Gheonea D; Dobru D; Dumitru E; Prelipcean CC; Gîlcă-Blanariu GE; Moscalu M; Stanciu C; Trifan A J Gastrointestin Liver Dis; 2021 Sep; 30(3):346-357. PubMed ID: 34375380 [TBL] [Abstract][Full Text] [Related]
12. Characterization and prevalence of extraintestinal manifestations in a cohort of patients with inflammatory intestinal disease in Medellin, Colombia. Juliao-Baños F; Arrubla M; Osorio L; Camargo J; Londoño J; Cáceres C; Carvajal J; Mosquera-Klinger G; Donado J Gastroenterol Hepatol; 2021; 44(6):398-404. PubMed ID: 33172691 [TBL] [Abstract][Full Text] [Related]
13. Smoking increases the risk of extraintestinal manifestations in Crohn's disease. Ott C; Takses A; Obermeier F; Schnoy E; Müller M World J Gastroenterol; 2014 Sep; 20(34):12269-76. PubMed ID: 25232261 [TBL] [Abstract][Full Text] [Related]
14. The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients. Roth R; Vavricka S; Scharl M; Schreiner P; Safroneeva E; Greuter T; Zeitz J; Misselwitz B; Schoepfer A; Barry MP; Rogler G; Biedermann L; United European Gastroenterol J; 2021 Sep; 9(7):773-780. PubMed ID: 34431613 [TBL] [Abstract][Full Text] [Related]
15. Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking. Roberts H; Rai SN; Pan J; Rao JM; Keskey RC; Kanaan Z; Short EP; Mottern E; Galandiuk S Digestion; 2014; 90(2):122-9. PubMed ID: 25277851 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of infliximab for extraintestinal manifestations of inflammatory bowel disease. Siemanowski B; Regueiro M Curr Treat Options Gastroenterol; 2007 Jun; 10(3):178-84. PubMed ID: 17547856 [TBL] [Abstract][Full Text] [Related]
17. Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations. He R; Zhao S; Cui M; Chen Y; Ma J; Li J; Wang X Front Immunol; 2023; 14():1234535. PubMed ID: 37954590 [TBL] [Abstract][Full Text] [Related]
18. Fecal microbiota is associated with extraintestinal manifestations in inflammatory bowel disease. Hertz S; Anderson JM; Nielsen HL; Schachtschneider C; McCauley KE; Özçam M; Larsen L; Lynch SV; Nielsen H Ann Med; 2024 Dec; 56(1):2338244. PubMed ID: 38648495 [TBL] [Abstract][Full Text] [Related]
19. A Study of the Epidemiology, Clinical, and Phenotypic Characteristics of Inflammatory Bowel Disease in the Northen-Central Region of Saudi Arabia. Al-Fawzan AA; Al-Radhi SA; Al-Omar AS; Al-Mutiri NH; Al-Ammari AM; El-Gohary M; Shamsan AN; Al Shehri HM; ALGhasab NS Diagnostics (Basel); 2023 Jun; 13(13):. PubMed ID: 37443529 [TBL] [Abstract][Full Text] [Related]
20. Severe Disease Activity Based on the Paris Classification Is Associated with the Development of Extraintestinal Manifestations in Korean Children and Adolescents with Ulcerative Colitis. Jang HJ; Suh HR; Choi S; Hong SJ; Cho SM; Choi KH; Choe BH; Kang B; J Korean Med Sci; 2021 Nov; 36(44):e278. PubMed ID: 34783212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]